ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is -28.43.
| Share Price | ₹752.1 | Dec 15,2025 |
| Market Cap | ₹428.7 Cr | |
| Earnings-TTM | ₹-15.1 Cr | TTM-Standalone Results |
| Price/Earnings | -28.43x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹428.7 Cr] as on Dec 15,2025
(/) Earnings [ ₹-15.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -28.43x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay -28.43 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.29x.
- ALBERT DAVID 's operated at median p/e ratio of 8.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2025 at 26.92x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 8.08x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALBERT DAVID | -15.08 | -28.43 | 428.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 41.00 | 431,220.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 67.80 | 168,486.0 |
| CIPLA LTD | 5,453.86 | 22.32 | 121,751.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 59.80 | 127,963.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.68 | 106,866.0 |
| MANKIND PHARMA LTD | 1,767.06 | 50.06 | 88,460.0 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.64 | 92,699.3 |
| LUPIN LTD | 4,347.53 | 21.96 | 95,477.8 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.97 | 68,854.0 |
| ABBOTT INDIA LTD | 1,508.95 | 39.28 | 59,275.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -28.43x |
| Max industry PE | 67.80x |
| Median industry PE | 22.32x |
| Average industry PE | 30.10x |
You may also like the below Video Courses